7105US snRNP-C (FDA cleared)
Intended Use:
AESKULISA snRNP-C is a solid phase enzyme immunoassay for the quantitative and qualitative detection of antibodies against the snRNP complex in human serum.
Recombinant Antigens:
n.a.
Native Antigens:
snRNP Complex (snRNP/Sm)
Published in
Rheumatology (FDA cleared Products)
Tagged under